Publikationsliste - Marien Hospital Herne

Publikationsliste
Urologische Klinik
Marien Hospital Herne – Universitätsklinikum der Ruhr-Universität Bochum

2020

Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced
and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort
Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77
(2020) 223-250].
Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S,
James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Van Der Kwast T,
Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M,
Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas
R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, De
Visschere PJL, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S,
Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B,
Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H,
Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V,
Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V,
Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR,
N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, Oyen WJG,
Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M,
Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier
C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A,
Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Van Der Heijden AG,
Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T,
Wiklund P, Willemse PM, Williams A, Zigeuner R, Horwich A.Eur Urol. 2020
Jul;78(1):e48-e50. doi: 10.1016/j.eururo.2020.03.017. Epub 2020 May
21.PMID: 32446863 No abstract available.

The impact of treatment modality on survival in patients with clinical node-positive
bladder cancer: results from a multicenter collaboration.
Afferi L, Zamboni S, Karnes RJ, Roghmann F, Sargos P, Montorsi F, Briganti A, Gallina
A, Mattei A, Schulz GB, Hendricksen K, Voskuilen CS, Rink M, Poyet C, De Cobelli O,
di Trapani E, Simeone C, Soligo M, Simone G, Tuderti G, Alvarez-Maestro M,
Martínez-Piñeiro L, Aziz A, Shariat SF, Abufaraj M, Xylinas E, Moschini M; European
Association of Urology-Young Academic Urologists (EAU-YAU), Urothelial Carcinoma
Working Group.World J Urol. 2020 Apr 30. doi: 10.1007/s00345-020-03205-z. Online
ahead of print.PMID: 32356226

The role of device-assisted therapies in the management of non-muscle invasive
bladder cancer: A systematic review.
Carando R, Pradere B, Afferi L, Marra G, Aziz A, Roghmann F, Krajewski W, Di Bona
C, Alvarez-Maestro M, Pagliarulo V, Xylinas E, Moschini M.Prog Urol. 2020
May;30(6):322-331. doi: 10.1016/j.purol.2020.03.005. Epub 2020 Apr
9.PMID: 32279953

Early recovery after surgery for radical cystectomy: comprehensive assessment and
meta-analysis of existing protocols.
Wessels F, Lenhart M, Kowalewski KF, Braun V, Terboven T, Roghmann F, Michel MS,
Honeck P, Kriegmair MC.World J Urol. 2020 Mar 2. doi: 10.1007/s00345-020-03133-y.
Online ahead of print.PMID: 32124020

Minimally invasive cancer surgery is associated with a lower risk of venous
thromboembolic events.
Krimphove MJ, Reese S, Chen X, Marchese M, Cone E, Tully KH, Paciotti M, Kibel AS,
Melnitchouk N, Kluth LA, Dasgupta P, Trinh QD.J Surg Oncol. 2020 Mar;121(3):578-
583. doi: 10.1002/jso.25832. Epub 2020 Jan 8.PMID: 31916588

Facility-Level Variation in Pelvic Lymphadenectomy During Radical Prostatectomy and
Effect on Overall Survival in Men with High-Risk Prostate Cancer.
Friedlander DF, Krimphove MJ, Cole AP, Tully KH, Lipsitz SR, Kibel AS, Kilbridge KL,
Trinh QD.Ann Surg Oncol. 2020 Jun;27(6):1929-1936. doi: 10.1245/s10434-019-
08110-3. Epub 2019 Dec 17.PMID: 31848818

Temporal Trends in the Incidence of Testicular Cancer in the United States over the
Past Four Decades.
Reese SW, Tully KH, Nabi J, Paciotti M, Chou WH, Trinh QD.Eur Urol Oncol. 2020 Jul
11:S2588-9311(20)30089-4. doi: 10.1016/j.euo.2020.06.011. Online ahead of
print.PMID: 32665140

The cost of obesity in radical cystectomy.
Huynh MJ, Wang Y, Chang SL, Tully KH, Chung BI, Wright JL, Mossanen M.Urol
Oncol. 2020 Jun 30:S1078-1439(20)30218-0. doi: 10.1016/j.urolonc.2020.05.014.
Online ahead of print.PMID: 32620482

Determinants of self-reported functional status (EPIC-26) in prostate cancer patients
prior to treatment.
Roth R, Dieng S, Oesterle A, Feick G, Carl G, Hinkel A, Steiner T, Kaftan BT, Kunath F,
Hadaschik B, Oostdam SJ, Palisaar RJ, Koralewski M, Beyer B, Haben B, Tsaur I,
Wesselmann S, Kowalski C.World J Urol. 2020 Feb 10. doi: 10.1007/s00345-020-
03097-z. Online ahead of print.PMID: 32040715

A multicenter paper-based and web-based system for collecting patient-reported
outcome measures in patients undergoing local treatment for prostate cancer: first

experiences.
Kowalski C, Roth R, Carl G, Feick G, Oesterle A, Hinkel A, Steiner T, Brock M, Kaftan
B, Borowitz R, Zantl N, Heidenreich A, Neisius A, Darr C, Bolenz C, Beyer B,
Pfitzenmaier J, Brehmer B, Fichtner J, Haben B, Wesselmann S, Dieng S.J Patient Rep
Outcomes. 2020 Jul 13;4(1):56. doi: 10.1186/s41687-020-00224-
7.PMID: 32661594 Free PMC article.

Quantifying the Overall Survival Benefit With Early Radical Cystectomy for Patients
With Histologically Confirmed T1 Non-muscle-invasive Bladder Cancer.
Tully KH, Roghmann F, Noldus J, Chen X, Häuser L, Kibel AS, Sonpavde GP,
Mossanen M, Trinh QD.Clin Genitourin Cancer. 2020 Mar 31:S1558-7673(20)30075-6.
doi: 10.1016/j.clgc.2020.03.013. Online ahead of print.PMID: 32335060

Inequity in selective referral to high-volume hospitals for genitourinary malignancies.
Berg S, Tully KH, Sahraoui A, Tan WS, Krimphove MJ, Marchese M, Lipsitz
SR, Noldus J, Trinh QD.Urol Oncol. 2020 Jun;38(6):582-589. doi:
10.1016/j.urolonc.2020.02.013. Epub 2020 Mar 23.PMID: 32217041

Toward noninvasive follow-up of low-risk bladder cancer - Rationale and concept of the
UroFollow trial.
Benderska-Söder N, Hovanec J, Pesch B, Goebell PJ, Roghmann F, Noldus J,
Rabinovich J, Wichert K, Gleichenhagen J, Käfferlein HU, Köhler CU, Johnen G, Kernig
K, Hakenberg O, Jahn D, Todenhöfer T, Stenzl A, Gleissner J, Gerwert K, El-Mashtoly
S, Behrens T, Brüning T, Schmitz-Dräger BJ.Urol Oncol. 2020 Mar 18:S1078-
1439(20)30007-7. doi: 10.1016/j.urolonc.2020.01.006. Online ahead of
print.PMID: 32199755 Review.

Institutional Adoption and Apprenticeship of Fusion Targeted Prostate Biopsy: Does
Experience Affect the Cancer Detection Rate?
Berg S, Hanske J, von Landenberg N, Noldus J, Brock M.Urol Int. 2020;104(5-6):476-
482. doi: 10.1159/000505654. Epub 2020 Feb 7.PMID: 32036374

Association between Development of Metabolic Acidosis and Improvement of Urinary
Continence after Ileal Neobladder Creation.
Müller G, Butea-Bocu M, Brock O, Hanske J, Pucheril D, Noldus J, Otto U.J Urol. 2020
Mar;203(3):585-590. doi: 10.1097/JU.0000000000000583. Epub 2019 Oct
9.PMID: 31596652

Trends in Adherence to Thromboprophylaxis Guideline in Patients Undergoing Radical
Cystectomy.
Tully KH, Krimphove MJ, Reese SW, Kibel AS, Noldus J, Krasnow RE, Trinh QD,

Sonpavde GP, Chang SL, Mossanen M.Urology. 2020 Jan;135:44-49. doi:
10.1016/j.urology.2019.09.029. Epub 2019 Oct 3.PMID: 31586570 Clinical Trial.

2019
EAU-ESMO Consensus Statements on the Management of Advanced and Variant
Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the
Auspices of the EAU-ESMO Guidelines Committees.
Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S,
James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Der Kwast TV,
Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M,
Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas
R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, J L De
Visschere P, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S,
Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B,
Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H,
Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V,
Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V,
Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR,
N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, J G Oyen W,
Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M,
Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier
C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A,
Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Van Der Heijden AG,
Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T,
Wiklund P, Williams A, Zigeuner R, Horwich A.Eur Urol. 2020 Feb;77(2):223-250. doi:
10.1016/j.eururo.2019.09.035. Epub 2019 Nov 19.PMID: 31753752

EAU-ESMO consensus statements on the management of advanced and variant
bladder cancer-an international collaborative multi-stakeholder effort: under the
auspices of the EAU and ESMO Guidelines Committees†.
Horwich A, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S,
James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Van Der Kwast T,
Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M,
Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas
R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, DeBlok W, De
Visschere PJL, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S,
Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B,
Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H,
Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V,
Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V,
Lorch A, Loriot Y, Meijer R, Carmen Mir M, Moschini M, Mostafid H, Müller AC, Müller
CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, Oyen WJG,
Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M,
Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier
C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A,
Thalmann GN, Tombal B, Turkbey B, Vahr Lauridsen S, Valdagni R, Van Der Heijden
AG, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Vives Rivera FA, Wiegel
T, Wiklund P, Williams A, Zigeuner R, Witjes JA.Ann Oncol. 2019 Nov 1;30(11):1697-

1727. doi: 10.1093/annonc/mdz296.PMID: 31740927

Psychometric validation of the German version of the EPIC-26 questionnaire for
patients with localized and locally advanced prostate cancer.
Sibert NT, Dieng S, Oesterle A, Feick G, Carl G, Steiner T, Minner J, Roghmann F,
Kaftan B, Zengerling F, Hinkel A, Beyer B, Heidenreich A, Harke N, Brehmer B,
Pfitzenmaier J, Fichtner J, Neisius A, Hammerer P, Wesselmann S, Kowalski C.World J
Urol. 2019 Sep 24. doi: 10.1007/s00345-019-02949-7. Online ahead of
print.PMID: 31552467

The need to improve TURB: a diagnostic and therapeutic fundamental first step in the
disease's management.
Moschini M, Roghmann F, Xylinas E.Transl Androl Urol. 2019 Feb;8(1):2-4. doi:
10.21037/tau.2018.08.29.PMID: 30976561 Free PMC article. No abstract available.

Botulinumtoxin for bladder disorders.
Schulte-Baukloh H, Bauer R, Jost W, Wissel J, van Ophoven A. Fortschr Neurol
Psychiatr. 2019 Feb;87(1):23-30. doi: 10.1055/a-0599-0697. Epub 2018 Dec 3. PMID:
30508871 Review. German.

Efficacy of pentosan polysulfate for the treatment of interstitial cystitis/bladder pain
syndrome: results of a systematic review of randomized controlled trials.
van Ophoven A, Vonde K, Koch W, Auerbach G, Maag KP. Curr Med Res Opin. 2019
Sep;35(9):1495-1503. doi: 10.1080/03007995.2019.1586401. Epub 2019 Mar 19.
PMID: 30849922

Re: Birder LA, Wolf-Johnston AS, Jackson EK, Wein AJ, Dmochowski R. Aging
increases the expression of vasopressin receptors in both the kidney and urinary
bladder. Neurourol Urodyn. 2019 Jan;38(1):393-397.
van Ophoven A, Heinze K. Neurourol Urodyn. 2019 Mar;38(3):1026. doi:
10.1002/nau.23933. Epub 2019 Feb 22. PMID: 30801811 No abstract available.

Neoadjuvant Androgen Deprivation Therapy Prior to Radical Prostatectomy: Recent
Trends in Utilization and Association with Postoperative Surgical Margin Status.
McClintock TR, von Landenberg N, Cole AP, Lipsitz SR, Gild P, Sun M, Fletcher
SA, Roghmann F, Menon M, Nguyen PL, Noldus J, Choueiri TK, Kibel AS, Trinh
QD.Ann Surg Oncol. 2019 Jan;26(1):297-305. doi: 10.1245/s10434-018-7035-z. Epub
2018 Nov 14.PMID: 30430324

Discrepancy Between European Association of Urology Guidelines and Daily Practice

in the Management of Non-muscle-invasive Bladder Cancer: Results of a European
Survey.
Hendricksen K, Aziz A, Bes P, Chun FK, Dobruch J, Kluth LA, Gontero P, Necchi A,
Noon AP, van Rhijn BWG, Rink M, Roghmann F, Rouprêt M, Seiler R, Shariat SF,
Qvick B, Babjuk M, Xylinas E; Young Academic Urologists Urothelial Carcinoma Group
of the European Association of Urology.Eur Urol Focus. 2019 Jul;5(4):681-688. doi:
10.1016/j.euf.2017.09.002. Epub 2017 Oct 23.PMID: 29074050

Comparing Long-Term Outcomes Following Radical and Partial Nephrectomy for cT1
Renal Cell Carcinoma in Young and Healthy Individuals.
Tan WS, Berg S, Cole AP, Krimphove M, Marchese M, Lipsitz SR, Nabi J, Sammon JD,
Choueiri TK, Kibel AS, Sun M, Chang S, Trinh QD.JNCI Cancer Spectr. 2019 Feb
1;3(1):pkz003. doi: 10.1093/jncics/pkz003. eCollection 2019 Mar.PMID: 31360891 Free
PMC article.

Variation in Positive Surgical Margin Status After Radical Prostatectomy for pT2
Prostate Cancer.
Tan WS, Krimphove MJ, Cole AP, Marchese M, Berg S, Lipsitz SR, Löppenberg B,
Nabi J, Abdollah F, Choueiri TK, Kibel AS, Sooriakumaran P, Trinh QD.Clin Genitourin
Cancer. 2019 Oct;17(5):e1060-e1068. doi: 10.1016/j.clgc.2019.06.008. Epub 2019 Jun
19.PMID: 31303561

Reply to Michael Froehner and Christian Thomas's Letter to the Editor re: Sebastian
Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of
Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in
Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5.
Berg S, Cole A, Trinh QD.Eur Urol. 2019 Sep;76(3):e76-e77. doi:
10.1016/j.eururo.2019.05.040. Epub 2019 Jun 4.PMID: 31174890 No abstract
available.

Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal
access overcome race-based differences in survival?
Cole AP, Fletcher SA, Berg S, Nabi J, Mahal BA, Sonpavde GP, Nguyen PL, Lipsitz
SR, Sun M, Choueiri TK, Preston MA, Kibel AS, Trinh QD.Cancer. 2019 Apr
15;125(8):1319-1329. doi: 10.1002/cncr.31926. Epub 2019 Jan
11.PMID: 30633323 Free article.

Quality of Care in the Treatment of Localized Intermediate and High Risk Prostate
Cancer at Minority Serving Hospitals.
Krimphove MJ, Fletcher SA, Cole AP, Berg S, Sun M, Lipsitz SR, Mahal BA, Nguyen
PL, Choueiri TK, Kibel AS, Kluth LA, Weissman JS, Trinh QD.J Urol. 2019
Apr;201(4):735-741. doi: 10.1016/j.juro.2018.10.024.PMID: 30414956 Clinical Trial.

Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer
Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes
Only: A Propensity Score-based Analysis.
Necchi A, Mariani L, Lo Vullo S, Yu EY, Woods ME, Wong YN, Harshman LC, Alva A,
Sternberg CN, Bamias A, Grivas P, Koshkin VS, Roghmann F, Dobruch J, Eigl BJ,
Nappi L, Milowsky MI, Niegisch G, Pal SK, De Giorgi U, Recine F, Vaishampayan U,
Berthold DD, Bowles DW, Baniel J, Theodore C, Ladoire S, Srinivas S, Agarwal N,
Crabb S, Sridhar S, Golshayan AR, Ohlmann C, Xylinas E, Powles T, Rosenberg JE,
Bellmunt J, van Rhijn B, Galsky MD, Hendricksen K; Young Academic Urologists-
Urothelial Carcinoma Group-European Association of Urology and the Retrospective
International Study of Invasive/Advanced Cancer of the Urothelium group.Eur Urol
Focus. 2019 Mar;5(2):242-249. doi: 10.1016/j.euf.2017.05.006. Epub 2017 Jun
3.PMID: 28753897 Free PMC article. Clinical Trial.

Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer
Do Not Explain the Overall Survival Discrepancy.
Krimphove MJ, Szymaniak J, Marchese M, Tully KH, D'Andrea D, Mossanen M, Lipsitz
SR, Kilbridge K, Kibel AS, Kluth LA, Shariat SF, Trinh QD.Eur Urol Focus. 2019 Jun
18:S2405-4569(19)30156-7. doi: 10.1016/j.euf.2019.06.001. Online ahead of
print.PMID: 31227463

Adoption of immunotherapy in the community for patients diagnosed with metastatic
melanoma.
Krimphove MJ, Tully KH, Friedlander DF, Marchese M, Ravi P, Lipsitz SR, Kilbridge
KL, Kibel AS, Kluth LA, Ott PA, Choueiri TK, Trinh QD.J Immunother Cancer. 2019 Nov
7;7(1):289. doi: 10.1186/s40425-019-0782-y.PMID: 31699149 Free PMC article.

Evaluation of the contribution of demographics, access to health care, treatment, and
tumor characteristics to racial differences in survival of advanced prostate cancer.
Krimphove MJ, Cole AP, Fletcher SA, Harmouch SS, Berg S, Lipsitz SR, Sun M, Nabi
J, Nguyen PL, Hu JC, Kibel AS, Choueiri TK, Kluth LA, Trinh QD.Prostate Cancer
Prostatic Dis. 2019 Mar;22(1):125-136. doi: 10.1038/s41391-018-0083-4. Epub 2018
Aug 31.PMID: 30171227

The value of nephrometry scoring systems in prediction of conversion to radical
nephrectomy in patients scheduled for nephron-sparing surgery.
Haeuser L, Dahlkamp L, Noldus J, Roghmann F.Ann Transl Med. 2019 Nov;7(22):704.
doi: 10.21037/atm.2019.11.09.PMID: 31930105 Free PMC article. No abstract
available.

Differences in survival and impact of adjuvant chemotherapy in patients with variant
histology of tumors of the renal pelvis.
Tully KH, Krimphove Md MJ, Huynh MJ, Marchese M, Kibel AS, Noldus J, Kluth LA,
McGregor B, Chang SL, Trinh QD, Mossanen M.World J Urol. 2019 Nov 20. doi:
10.1007/s00345-019-03003-2. Online ahead of print.PMID: 31748954

Risk of Dementia and Depression in Young and Middle-aged Men Presenting with
Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy.
Tully KH, Nguyen DD, Herzog P, Jin G, Noldus J, Nguyen PL, Kibel AS, Sun M,
McGregor B, Basaria S, Trinh QD.Eur Urol Oncol. 2019 Oct 14:S2588-9311(19)30129-
4. doi: 10.1016/j.euo.2019.08.003. Online ahead of print.PMID: 31624049

Reply by Authors.
Dahlkamp L, Haeuser L, Winnekendonk G, von Bodman C, Frey UH, Epplen R,
Palisaar RJ, Bach P,Noldus J, Brock M, Roghmann F.J Urol. 2019 Nov;202(5):897-898.
doi: 10.1097/01.JU.0000580464.59886.eb. Epub 2019 Oct 9.PMID: 31430241 No
abstract available.

Editorial: early PSA-testing after radical prostatectomy-the truth behind the scenes.
Hanske J, Roghmann F, Noldus J, Brock M.Transl Androl Urol. 2019 Jul;8(Suppl
3):S307-S309. doi: 10.21037/tau.2019.06.08.PMID: 31392154 Free PMC article. No
abstract available.

Salvage lymph node dissection in hormone-naïve men: How effective is surgery?
Hanske J, Ostholt J, Roghmann F, Müller G, Braun K, Gomez B, von Landenberg N,
von Bodman C, Palisaar RJ, Liermann D, Noldus J, Brock M.Urol Oncol. 2019
Nov;37(11):812.e17-812.e24. doi: 10.1016/j.urolonc.2019.06.023. Epub 2019 Jul
18.PMID: 31327750

Interdisciplinary Comparison of PADUA and R.E.N.A.L. Scoring Systems for Prediction
of Conversion to Nephrectomy in Patients with Renal Mass Scheduled for Nephron
Sparing Surgery.
Dahlkamp L, Haeuser L, Winnekendonk G, von Bodman C, Frey UH, Epplen R,
Palisaar RJ, Bach P,Noldus J, Brock M, Roghmann F.J Urol. 2019 Nov;202(5):890-898.
doi: 10.1097/JU.0000000000000361. Epub 2019 Oct 9.PMID: 31145034

Parastomal Hernia Repair With 3-D Mesh Implants After Radical Cystectomy and Ileal
Conduit Urinary Diversion - A Single-center Experience Using a Purpose Made
Alloplastic Mesh Implant.
Tully KH, Roghmann F, Pastor J, Noldus J, von Bodman C.Urology. 2019 Sep;131:245-
249. doi: 10.1016/j.urology.2019.05.006. Epub 2019 May 23.PMID: 31129194

Noninvasive diagnosis of urothelial cancer in urine using DNA hypermethylation
signatures-Gender matters.
Köhler CU, Bonberg N, Ahrens M, Behrens T, Hovanec J, Eisenacher M, Noldus J,
Deix T, Braun K, Gohlke H, Walter M, Tannapfel A, Tam Y, Sommerer F, Marcus K,
Jöckel KH, Erbel R, Cantor CR, Käfferlein HU, Brüning T.Int J Cancer. 2019 Nov
15;145(10):2861-2872. doi: 10.1002/ijc.32356. Epub 2019 May 16.PMID: 31008534

Transurethral resection of bladder tumours: established and new methods of tumour
visualisation.
Tully K, Palisaar RJ, Brock M, Bach P, von Landenberg N, Löppenberg B, von Bodman
C, Noldus J, Roghmann F.Transl Androl Urol. 2019 Feb;8(1):25-33. doi:
10.21037/tau.2018.12.12.PMID: 30976565 Free PMC article. Review.

Integrated Fourier Transform Infrared Imaging and Proteomics for Identification of a
Candidate Histochemical Biomarker in Bladder Cancer.
Witzke KE, Großerueschkamp F, Jütte H, Horn M, Roghmann F, von Landenberg N,
Bracht T, Kallenbach-Thieltges A, Käfferlein H, Brüning T, Schork K, Eisenacher M,
Marcus K, Noldus J, Tannapfel A, Sitek B, Gerwert K.Am J Pathol. 2019
Mar;189(3):619-631. doi: 10.1016/j.ajpath.2018.11.018. Epub 2019 Feb
12.PMID: 30770125 Free article. Clinical Trial.

Facility Level Variation in Rates of Definitive Therapy for Low Risk Prostate Cancer in
Men with Limited Life Expectancy: An Opportunity for Value Based Care Redesign.
Friedlander DF, von Landenberg N, Löppenberg B, Noldus J, Lipsitz SR, Cole AP,
Abdollah F, Nguyen PL, Choueiri TK, Kibel AS, Trinh QD.J Urol. 2019 Apr;201(4):728-
734. doi: 10.1097/JU.0000000000000006.PMID: 30633112

Impact of adjuvant chemotherapy in patients with adverse features and variant
histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does
histologic subtype matter?
Berg S, D'Andrea D, Vetterlein MW, Cole AP, Fletcher SA, Krimphove MJ, Marchese
M, Lipsitz SR, Sonpavde G, Noldus J, Shariat SF, Kibel AS, Trinh QD, Mossanen
M.Cancer. 2019 May 1;125(9):1449-1458. doi: 10.1002/cncr.31952. Epub 2019 Jan
8.PMID: 30620387 Free article.

Neoadjuvant Androgen Deprivation Therapy Prior to Radical Prostatectomy: Recent
Trends in Utilization and Association with Postoperative Surgical Margin Status.
McClintock TR, von Landenberg N, Cole AP, Lipsitz SR, Gild P, Sun M, Fletcher SA,
Roghmann F, Menon M, Nguyen PL, Noldus J, Choueiri TK, Kibel AS, Trinh QD.Ann
Surg Oncol. 2019 Jan;26(1):297-305. doi: 10.1245/s10434-018-7035-z. Epub 2018 Nov
14.PMID: 30430324

Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation
Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer.
Berg S, Cole AP, Krimphove MJ, Nabi J, Marchese M, Lipsitz SR, Noldus J, Choueiri
TK, Kibel AS, Trinh QD.Eur Urol. 2019 Apr;75(4):552-555. doi:
10.1016/j.eururo.2018.10.032. Epub 2018 Nov 10.PMID: 30420255

TGFBI Protein Is Increased in the Urine of Patients with High-Grade Urothelial
Carcinomas, and Promotes Cell Proliferation and Migration.
Lang K, Kahveci S, Bonberg N, Wichert K, Behrens T, Hovanec J, Roghmann
F, Noldus J, Tam YC, Tannapfel A, Käfferlein HU, Brüning T.Int J Mol Sci. 2019 Sep
11;20(18):4483. doi: 10.3390/ijms20184483.PMID: 31514337 Free PMC article.

High proliferation rate and TNM stage but not histomorphological subtype are
independent prognostic markers for overall survival in papillary renal cell carcinoma.
Polifka I, Agaimy A, Herrmann E, Spath V, Trojan L, Stöckle M, Becker F, Ströbel P,
Wülfing C, Schrader AJ, Barth P, Staehler M, Stief C, Hohenfellner M, Macher-
Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M,
Höfler H, Haferkamp A, Geppert CI, Stöhr C, Hartmann A; German Network Of Kidney
Cancer.Hum Pathol. 2019 Jan;83:212-223. doi: 10.1016/j.humpath.2018.08.006. Epub
2018 Aug 17.PMID: 30121370

2018

[Sacral neuromodulation for refractory overactive bladder].
van Ophoven A. Urologe A. 2018 Nov;57(11):1375-1388. doi: 10.1007/s00120-018-
0777-1. PMID: 30310935 German.

De novo neurogenic bladder dysfunction after salvage lymph node dissection in
patients with nodal recurrence of prostate cancer.
Hanske J, Müller G, van Ophoven A, von Landenberg N, Roghmann F, Palisaar RJ,
von Bodman C, Noldus J, Brock M. Neurourol Urodyn. 2018 Aug;37(6):1988-1995. doi:
10.1002/nau.23545. Epub 2018 Mar 5. PMID: 29504654

The present and future of non-muscle invasive bladder cancer.
Moschini M, Roghmann F, Xylinas E.Transl Androl Urol. 2019 Feb;8(1):1. doi:
10.21037/tau.2019.02.02.PMID: 30976560 Free PMC article. No abstract available.

Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics
and Clinical Outcomes.
Voskuilen CS, Seiler R, Rink M, Poyet C, Noon AP, Roghmann F, Necchi A, Aziz A,
Lavollé A, Young MJ, Marks P, Saba K, van Rhijn BWG, Fransen van de Putte EE,
Ablat J, Black PC, Sosnowski R, Dobruch J, Kumar P, Jallad S, Catto JWF, Xylinas E,
Hendricksen K; Young Academic Urologists’ Working Group on Urothelial Carcinoma of
the European Association of Urology.Eur Urol Focus. 2018 Dec 14:S2405-
4569(18)30382-1. doi: 10.1016/j.euf.2018.12.002. Online ahead of
print.PMID: 30559065

Conditional analyses of recurrence and progression in patients with TaG1 non-muscle-
invasive bladder cancer.
von Landenberg N, Aziz A, von Rundstedt FC, Dobruch J, Kluth LA, Necchi A, Noon A,
Rink M, Hendricksen K, Decaestecker KPJ, Seiler R, Poyet C, Fajkovic H, Shariat SF,
Xylinas E, Roghmann F; Young Academic Urologists′ Working Group on Urothelial
Cancer of the European Association of Urology.Urol Oncol. 2018 May;36(5):238.e19-
238.e27. doi: 10.1016/j.urolonc.2018.01.017. Epub 2018 Mar
3.PMID: 29506940 Clinical Trial

Recommendations for follow-up of muscle-invasive bladder cancer patients: A
consensus by the international bladder cancer network.
Zuiverloon TCM, van Kessel KEM, Bivalacqua TJ, Boormans JL, Ecke TH, Grivas PD,
Kiltie AE, Liedberg F, Necchi A, van Rhijn BW, Roghmann F, Sanchez-Carbayo M,
Schmitz-Dräger BJ, Wezel F, Kamat AM.Urol Oncol. 2018 Sep;36(9):423-431. doi:
10.1016/j.urolonc.2018.01.014. Epub 2018 Mar 2.PMID: 29496372 Review.

Comparing Adjuvant vs Early-Salvage Radiotherapy After Radical Prostatectomy.
Berg S, Nabi J, Trinh QD.JAMA Oncol. 2018 Nov 1;4(11):1619-1620. doi:
10.1001/jamaoncol.2018.3536.PMID: 30422246 No abstract available.

Characterizing trends in treatment modalities for localized muscle-invasive bladder
cancer in the pre-immunotherapy era.
Fletcher SA, Harmouch SS, Krimphove MJ, Cole AP, Berg S, Gild P, Preston MA,
Sonpavde GP, Kibel AS, Sun M, Choueiri TK, Trinh QD.World J Urol. 2018
Nov;36(11):1767-1774. doi: 10.1007/s00345-018-2371-y. Epub 2018 Jun
14.PMID: 29948050

Adoption of robotic surgery: driven by market competition or a desire to improve patient
care?
Fletcher SA, Cole AP, Berg S, Pucheril D, Trinh QD.Lancet Oncol. 2018 Feb;19(2):e66.
doi: 10.1016/S1470-2045(18)30021-4.PMID: 29413467 No abstract available.

The new frontier of prostate biopsy: determining the role of image-guidance in moving
the needle.
Fletcher SA, Berg S, Trinh QD.BJU Int. 2018 Jan;121(1):4-5. doi:
10.1111/bju.14052.PMID: 29314538 Free article. No abstract available.

Evaluation of magnetic resonance imaging and targeted biopsy: The difficulty of finding
the right reference standard.
Berg S, Fletcher SA, Cole AP, Trinh QD.Cancer. 2018 Mar 15;124(6):1299-1300. doi:
10.1002/cncr.31201. Epub 2017 Dec 19.PMID: 29266175 Free article. No abstract
available.

Impact of testosterone replacement therapy on thromboembolism, heart disease and
obstructive sleep apnoea in men.
Cole AP, Hanske J, Jiang W, Kwon NK, Lipsitz SR, Kathrins M, Learn PA, Sun M,
Haider AH, Basaria S, Trinh QD.BJU Int. 2018 May;121(5):811-818. doi:
10.1111/bju.14149. Epub 2018 Feb 27.PMID: 29383868 Free article.

Use of Preventive Health Services Among Cancer Survivors in the U.S.
Gupta S, Cole AP, Marchese M, Wang Y, Speed JM, Fletcher SA, Nabi J, Berg S,
Lipsitz SR, Choueiri TK, Chang SL, Kibel AS, Uhlig A, Trinh QD.Am J Prev Med. 2018
Dec;55(6):830-838. doi: 10.1016/j.amepre.2018.07.021. Epub 2018 Oct
21.PMID: 30352719

Investigating the effect of treatment at high-volume hospitals on overall survival
following cytoreductive nephrectomy.
Berg S, Cole AP, Fletcher SA, Pucheril D, Nabi J, Lipsitz SR, Chang SL, Sun
M, Noldus J, Harshman LC, Choueiri TK, Trinh QD.Urol Oncol. 2018
Sep;36(9):400.e15-400.e22. doi: 10.1016/j.urolonc.2018.06.005.PMID: 30274640

Short-term external ureter stenting shows significant benefit in comparison to routine
double-J stent placement after ureterorenoscopic stone extraction: A prospective
randomized trial - the Fast track stent study (FaST).
Bach P, Reicherz A, Teichman J, Dahlkamp L, von Landenberg N, Palisaar RJ, Noldus
J, von Bodman C.Int J Urol. 2018 Aug;25(8):717-722. doi: 10.1111/iju.13711. Epub
2018 Jun 7.PMID: 29882261 Clinical Trial.

[Radical cystectomy and urinary diversion-what is important ?].
Noldus J, Niegisch G, Pycha A, Karl A.Urologe A. 2018 Jun;57(6):673-678. doi:
10.1007/s00120-018-0648-9.PMID: 29696301 Review. German.

De novo neurogenic bladder dysfunction after salvage lymph node dissection in
patients with nodal recurrence of prostate cancer.
Hanske J, Müller G, van Ophoven A, von Landenberg N, Roghmann F, Palisaar RJ,
von Bodman C,Noldus J, Brock M.Neurourol Urodyn. 2018 Aug;37(6):1988-1995. doi:
10.1002/nau.23545. Epub 2018 Mar 5.PMID: 29504654

Impact of adequate pelvic lymph node dissection on overall survival after radical
cystectomy: A stratified analysis by clinical stage and receipt of neoadjuvant
chemotherapy.
von Landenberg N, Speed JM, Cole AP, Seisen T, Lipsitz SR, Gild P, Menon M, Kibel
AS, Roghmann F,Noldus J, Sun M, Trinh QD.Urol Oncol. 2018 Feb;36(2):78.e13-
78.e19. doi: 10.1016/j.urolonc.2017.10.021. Epub 2017 Nov 21.PMID: 29169845

Peri-operative allogeneic blood transfusion does not adversely affect oncological
outcomes after radical cystectomy for urinary bladder cancer: a propensity score-
weighted European multicentre study.
Vetterlein MW, Gild P, Kluth LA, Seisen T, Gierth M, Fritsche HM, Burger M, Protzel C,
Hakenberg OW, von Landenberg N, Roghmann F, Noldus J, Nuhn P, Pycha A, Rink M,
Chun FK, May M, Fisch M, Aziz A; PROMETRICS 2011 Study Group.BJU Int. 2018
Jan;121(1):101-110. doi: 10.1111/bju.14012. Epub 2017 Oct
11.PMID: 28905486 Clinical Trial.

Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally
Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of
the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
Vetterlein MW, Seisen T, May M, Nuhn P, Gierth M, Mayr R, Fritsche HM, Burger M,
Novotny V, Froehner M, Wirth MP, Protzel C, Hakenberg OW, Roghmann F, Palisaar
RJ, Noldus J, Pycha A, Bastian PJ, Trinh QD, Xylinas E, Shariat SF, Rink M, Chun FK,
Dahlem R, Fisch M, Aziz A; PROMETRICS 2011 Study Group.Eur Urol Focus. 2018
Mar;4(2):252-259. doi: 10.1016/j.euf.2016.07.001. Epub 2016 Jul 18.PMID: 28753775

Variation in the use of active surveillance for low-risk prostate cancer.Löppenberg B,
Friedlander DF, Krasnova A, Tam A, Leow JJ, Nguyen PL, Barry H, Lipsitz SR,
Menon M, Abdollah F, Sammon JD, Sun M, Choueiri TK, Kibel AS, Trinh QD.Cancer
Cytopathol. 2018 Jan 1;124(1):55-64. doi: 10.1002/cncr.30983. Epub 2017 Sep
13.PMID:28902401

2017

Testing the external validity of the European Organization for Research and Treatment
of Cancer randomized trial 30904 comparing overall survival after radical nephrectomy
vs nephron-sparing surgery in contemporary North American patients with renal cell
cancer.Abdollah F, Arora S, von Landenberg N, Gild P, Sood A, Dalela D, Trinh QD,

Menon M, Rogers C.BJU Int. 2017 Oct 3. doi: 10.1111/bju.14039. [Epub ahead of
print] No abstract available. PMID:28972695

Do micropapillary patients benefit from chemotherapy?von Landenberg N, Speed JM,
Trinh QD.BJU Int. 2017 May;119(5):656-658. doi: 10.1111/bju.13780. No abstract
available. PMID:28393496

Editorial Comment.Cole AP, von Landenberg N, Trinh QD.J Urol. 2017
May;197(5):1206-1207. doi: 10.1016/j.juro.2016.12.124. Epub 2017 Feb 9. No
abstract available. PMID:28189557

Challenging Residual Contamination of Instruments for Robotic Surgery in Japan.
von Landenberg N, Cole AP, Gild P, Trinh QD.Infect Control Hosp Epidemiol. 2017
Apr;38(4):501-502. doi: 10.1017/ice.2016.334. Epub 2017 Jan 31. No abstract
available. PMID:28137331

Evaluation of magnetic resonance imaging and targeted biopsy: The difficulty of
finding the right reference standard.Berg S, Fletcher SA, Cole AP, Trinh QD.Cancer.
2017 Dec 19. doi: 10.1002/cncr.31201. [Epub ahead of print] No abstract available.
PMID:29266175

Do we have biomarkers to predict response to neoadjuvant and adjuvant
chemotherapy and immunotherapy in bladder cancer?Wezel F, Vallo S, Roghmann
F; Young Academic Urologist Urothelial Carcinoma Group of the European
Association of Urology.Transl Androl Urol. 2017 Dec;6(6):1067-1080. doi:
10.21037/tau.2017.09.18. Review.PMID:29354494

Soluble chemokine (C-X-C motif) ligand 16 (CXCL16) in urine as a novel biomarker
candidate to identify high grade and muscle invasive urothelial carcinomas.Lang K,
Bonberg N, Robens S, Behrens T, Hovanec J, Deix T, Braun K, Roghmann F, Noldus
J, Harth V, Jöckel KH, Erbel R, Tam YC, Tannapfel A, Käfferlein HU, Brüning
T.Oncotarget. 2017 Sep 8;8(62):104946-104959. doi: 10.18632/oncotarget.20737.
eCollection 2017 Dec 1.PMID:29285224

Impact of adequate pelvic lymph node dissection on overall survival after radical
cystectomy: A stratified analysis by clinical stage and receipt of neoadjuvant
chemotherapy.von Landenberg N, Speed JM, Cole AP, Seisen T, Lipsitz SR, Gild P,
Menon M, Kibel AS, Roghmann F, Noldus J, Sun M, Trinh QD.Urol Oncol. 2018
Feb;36(2):78.e13-78.e19. doi: 10.1016/j.urolonc.2017.10.021. Epub 2017 Nov
21.PMID:29169845

Discrepancy Between European Association of Urology Guidelines and Daily Practice
in the Management of Non-muscle-invasive Bladder Cancer: Results of a European
Survey.Hendricksen K, Aziz A, Bes P, Chun FK, Dobruch J, Kluth LA, Gontero P,
Necchi A, Noon AP, van Rhijn BWG, Rink M, Roghmann F, Rouprêt M, Seiler R,
Shariat SF, Qvick B, Babjuk M, Xylinas E; Young Academic Urologists Urothelial
Carcinoma Group of the European Association of Urology.Eur Urol Focus.

2017 Oct 23. pii: S2405-4569(17)30206-7. doi: 10.1016/j.euf.2017.09.002. [Epub
ahead of print]PMID:29074050

Frequency and prognostic significance of incidental prostate cancer at radical
cystectomy: Results from an international retrospective study.Malte R, Kluth LA,
Kaushik D, Boorjian SA, Abufaraj M, Foerster B, Rink M, Gust K, Roghmann F,
Noldus J, Vordos D, Hagiwara M, Kikuchi E, Ikeda M, Matsumoto K, Karakiewicz PI,
Rouprêt M, Briganti A, Scherr DS, Shariat SF, Seebacher V.Eur J Surg Oncol. 2017
Nov;43(11):2193-2199. doi: 10.1016/j.ejso.2017.08.013. Epub 2017 Sep
7.PMID:28928012

Peri-operative allogeneic blood transfusion does not adversely affect oncological
outcomes after radical cystectomy for urinary bladder cancer: a propensity score-
weighted European multicentre study.Vetterlein MW, Gild P, Kluth LA, Seisen T,
Gierth M, Fritsche HM, Burger M, Protzel C, Hakenberg OW, von Landenberg N,
Roghmann F, Noldus J, Nuhn P, Pycha A, Rink M, Chun FK, May M, Fisch M, Aziz
A; PROMETRICS 2011 Study Group.BJU Int. 2018 Jan;121(1):101-110. doi:
10.1111/bju.14012. Epub 2017 Oct 11.PMID:28905486

Tobacco-Specific Carcinogens Induce Hypermethylation, DNA Adducts, and DNA
Damage in Bladder Cancer.Jin F, Thaiparambil J, Donepudi SR, Vantaku V,
Piyarathna DWB, Maity S, Krishnapuram R, Putluri V, Gu F, Purwaha P, Bhowmik
SK, Ambati CR, von Rundstedt FC, Roghmann F, Berg S, Noldus J, Rajapakshe K,
Gödde D, Roth S, Störkel S, Degener S, Michailidis G, Kaipparettu BA, Karanam B,
Terris MK, Kavuri SM, Lerner SP, Kheradmand F, Coarfa C, Sreekumar A, Lotan Y,
El-Zein R, Putluri N.Cancer Prev Res (Phila). 2017 Oct;10(10):588-597. doi:
10.1158/1940-6207.CAPR-17-0198. Epub 2017 Aug 29.PMID:28851690

Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer
Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes
Only: A Propensity Score-based Analysis.Necchi A, Mariani L, Lo Vullo S, Yu EY,
Woods ME, Wong YN, Harshman LC, Alva A, Sternberg CN, Bamias A, Grivas P,
Koshkin VS, Roghmann F, Dobruch J, Eigl BJ, Nappi L, Milowsky MI, Niegisch G, Pal
SK, De Giorgi U, Recine F, Vaishampayan U, Berthold DD, Bowles DW, Baniel J,
Theodore C, Ladoire S, Srinivas S, Agarwal N, Crabb S, Sridhar S, Golshayan AR,
Ohlmann C, Xylinas E, Powles T, Rosenberg JE, Bellmunt J, van Rhijn B, Galsky
MD, Hendricksen K; Young Academic Urologists-Urothelial Carcinoma Group-
European Association of Urology and the Retrospective International Study of
Invasive/Advanced Cancer of the Urothelium group.Eur Urol Focus. 2017 Jun 3. pii:
S2405-4569(17)30125-6. doi: 10.1016/j.euf.2017.05.006. [Epub ahead of
print]PMID:28753897

Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally
Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma
of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.Vetterlein
MW, Seisen T, May M, Nuhn P, Gierth M, Mayr R, Fritsche HM, Burger M, Novotny V,
Froehner M, Wirth MP, Protzel C, Hakenberg OW, Roghmann F, Palisaar RJ, Noldus
J, Pycha A, Bastian PJ, Trinh QD, Xylinas E, Shariat SF, Rink M, Chun FK, Dahlem
R, Fisch M, Aziz A; PROMETRICS 2011 Study Group.Eur Urol Focus. 2016
Jul 18. pii: S2405-4569(16)30099-2. doi: 10.1016/j.euf.2016.07.001. [Epub ahead of

print]PMID:28753775

Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in
paraneoplastic encephalitis.Popkirov S, Ayzenberg I, Hahn S, Bauer J, Denno Y,
Rieckhoff N, Radzimski C, Hans VH, Berg S, Roghmann F, Noldus J, Bien CG,
Skodda S, Wellmer J, Stöcker W, Krogias C, Gold R, Schlegel U, Probst C,
Komorowski L, Miske R, Kleiter I.Acta Neuropathol Commun. 2017 May 29;5(1):40.
doi: 10.1186/s40478-017-0447-3.PMID:28554330

Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and
Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer:
Results From a European Tertiary Care Center Cohort.Vetterlein MW, Meyer CP,
Leyh-Bannurah SR, Mayr R, Gierth M, Fritsche HM, Burger M, Keck B, Wullich B,
Martini T, Bolenz C, Pycha A, Hanske J, Roghmann F, Noldus J, Bastian PJ, Gilfrich
C, May M, Rink M, Chun FK, Dahlem R, Fisch M, Aziz A; PROMETRICS 2011 study
group.Clin Genitourin Cancer. 2017 Oct;15(5):e809-e817. doi:
10.1016/j.clgc.2017.04.021. Epub 2017 Apr 26.PMID:28550955

Noninvasive Diagnosis of High-Grade Urothelial Carcinoma in Urine by Raman
Spectral Imaging.Yosef HK, Krauß SD, Lechtonen T, Jütte H, Tannapfel A, Käfferlein
HU, Brüning T, Roghmann F, Noldus J, Mosig A, El-Mashtoly SF, Gerwert K.Anal
Chem. 2017 Jun 20;89(12):6893-6899. doi: 10.1021/acs.analchem.7b01403. Epub
2017 Jun 5.PMID:28541036

Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive
review.Aziz A, Dobruch J, Hendricksen K, Kluth LA, Necchi A, Noon A, Rink M,
Roghmann F, Seiler R, Gontero P, Kassouf W, Shariat SF, Xylinas E; Young
Academic Urologists Urothelial Carcinoma Group of the European Association of
Urology.World J Urol. 2017 Sep;35(9):1401-1407. doi: 10.1007/s00345-016-1995-
z. Epub 2017 Jan 10. Review.PMID:28074261

Association between the Surgical Apgar Score and Perioperative Complications after
Radical Prostatectomy.Orberger M, Palisaar J, Roghmann F, Mittelstädt L, Bischoff P,
Noldus J, Löppenberg B.Urol Int. 2017;98(1):61-70. doi: 10.1159/000450795.
Epub 2016 Dec 2.PMID:27907923

Is there evidence for a close connection between side of intravesical tumor location
and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at
radical cystectomy? Results of the PROMETRICS 2011 database.May M, Protzel C,
Vetterlein MW, Gierth M, Noldus J, Karl A, Grimm T, Wullich B, Grimm MO, Nuhn P,
Bastian PJ, Roigas J, Hadaschik B, Gilfrich C, Burger M, Fisch M, Brookman-May S,
Aziz A, Hakenberg OW; PROMETRICS 2011 Research Group.Int Urol Nephrol. 2017
Feb;49(2):247-254. doi: 10.1007/s11255-016-1469-7. Epub 2016 Nov
28.PMID:27896578

The Use of Neoadjuvant Chemotherapy in Patients With Urothelial Carcinoma of the
Bladder: Current Practice Among Clinicians.Martini T, Gilfrich C, Mayr R, Burger M,
Pycha A, Aziz A, Gierth M, Stief CG, Müller SC, Wagenlehner F, Roigas J,

Hakenberg OW, Roghmann F, Nuhn P, Wirth M, Novotny V, Hadaschik B, Grimm
MO, Schramek P, Haferkamp A, Colleselli D, Kloss B, Herrmann E, Fisch M, May M,
Bolenz C.Clin Genitourin Cancer. 2017 Jun;15(3):356-362. doi:
10.1016/j.clgc.2016.09.003. Epub 2016 Sep 19.PMID:27765613

[Modern networks : Topics in the working group "Bladder cancer research" of the
GeSRU Academics].Hofbauer S, Kalogirou C, Roghmann F, Seitz AK, Vallo S, Wezel
F, Worst T, Nawroth R.Urologe A. 2017 Feb;56(2):202-207. doi: 10.1007/s00120-
016-0217-z. Review. German. PMID:27604705

Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors
on the prognostic outcome after radical cystectomy: results from PROMETRICS
2011.May M, Fritsche HM, Vetterlein MW, Bastian PJ, Gierth M, Nuhn P, Aziz A,
Fisch M, Stief CG, Hohenfellner M, Wirth MP, Novotny V, Hakenberg OW, Noldus J,
Gilfrich C, Bolenz C, Burger M, Brookman-May SD; PROMETRICS 2011 Research
Group.World J Urol. 2017 Feb;35(2):245-250. doi: 10.1007/s00345-016-1877-4.
Epub 2016 Jun 14.PMID:27300339

Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder
cancer with variant histology.Vetterlein MW, Wankowicz SAM, Seisen T, Lander R,
Löppenberg B, Chun FK, Menon M, Sun M, Barletta JA, Choueiri TK, Bellmunt J,
Trinh QD, Preston MA.Cancer. 2017 Nov 15;123(22):4346-4355. doi:
10.1002/cncr.30907. Epub 2017 Jul 25.PMID:28743155

State-by-state Variation in Prostate-specific Antigen Screening Trends Following the
2011 United States Preventive Services Task Force Panel Update.Vetterlein MW,
Dalela D, Sammon JD, Karabon P, Sood A, Jindal T, Meyer CP, Löppenberg B, Sun
M, Trinh QD, Menon M, Abdollah F.Urology. 2017 Oct 19. pii: S0090-4295(17)31093-
2. doi: 10.1016/j.urology.2017.08.055. PMID:29056579

Variation in Locoregional Prostate Cancer Care and Treatment Trends at
Commission on Cancer Designated Facilities: A National Cancer Data Base Analysis
2004 to 2013.Löppenberg B, Sood A, Dalela D, Karabon P, Sammon JD, Vetterlein
MW, Noldus J, Peabody JO, Trinh QD, Menon M, Abdollah F.Clin Genitourin Cancer.
2017 Dec;15(6):e955-e968. doi: 10.1016/j.clgc.2017.04.014. Epub 2017 Apr
26.PMID:28558991

Impact of travel distance to the treatment facility on overall mortality in US patients
with prostate cancer.Vetterlein MW, Löppenberg B, Karabon P, Dalela D, Jindal T,
Sood A, Chun FK, Trinh QD, Menon M, Abdollah F.Cancer. 2017 Sep
1;123(17):3241-3252. doi: 10.1002/cncr.30744. Epub 2017 May 4.PMID:28472547

An Evaluation of the Timing of Surgical Complications Following Radical Cystectomy:
Data From the American College of Surgeons National Surgical Quality Improvement
Program.Sood A, Kachroo N, Abdollah F, Sammon JD, Löppenberg B, Jindal T, Sun
M, Trinh QD, Menon M, Peabody JO.Urology. 2017 May;103:91-98. doi:
10.1016/j.urology.2017.01.036. Epub 2017 Feb 16.PMID:28216450

Generalizability of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)
Results to Contemporary North American Men with Prostate Cancer.Dalela D,
Karabon P, Sammon J, Sood A, Löppenberg B, Trinh QD, Menon M, Abdollah F.Eur
Urol. 2017 Apr;71(4):511-514. doi: 10.1016/j.eururo.2016.08.048. Epub 2016
Sep 13.PMID:27638094

Resident Involvement in Radical Inguinal Orchiectomy for Testicular Cancer Does Not
Adversely Impact Perioperative Outcomes - A Retrospective Study.Vetterlein MW,
Seisen T, Löppenberg B, Hanna N, Cheng PJ, Fisch M, Chun FK, Kibel AS, Preston
MA, Meyer CP.Urol Int. 2017;98(4):472-477. doi: 10.1159/000448596. Epub
2016 Aug 31.PMID:27577733

2016

Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized
Prostate Cancer.Schmid M, Meyer CP, Reznor G, Choueiri TK, Hanske J, Sammon
JD, Abdollah F, Chun FK, Kibel AS, Tucker-Seeley RD, Kantoff PW, Lipsitz SR,
Menon M, Nguyen PL, Trinh QD.JAMA Oncol. 2016 Jan;2(1):85-93. doi:
10.1001/jamaoncol.2015.3384.PMID:26502115

Wound dehiscence in a sample of 1 776 cystectomies: identification of predictors and
implications for outcomes.Meyer CP, Rios Diaz AJ, Dalela D, Hanske J, Pucheril D,
Schmid M, Trinh VQ, Sammon JD, Menon M, Chun FK, Noldus J, Fisch M, Trinh
QD.BJU Int. 2016 Jun;117(6B):E95-E101. doi: 10.1111/bju.13213. Epub 2015 Jul
18.PMID:26118393

Differences in Prostate-Specific Antigen Testing Among Urologists and Primary Care
Physicians Following the 2012 USPSTF Recommendations.Zavaski ME, Meyer CP,
Sammon JD, Hanske J, Gupta S, Sun M, Trinh QD.JAMA Intern Med. 2016
Apr;176(4):546-7. doi: 10.1001/jamainternmed.2015.7901. No abstract available.
PMID:26857148

The impact of Medicare eligibility on cancer screening behaviors.Meyer CP, Allard CB,
Sammon JD, Hanske J, McNabb-Baltar J, Goldberg JE, Reznor G, Lipsitz SR,
Choueiri TK, Nguyen PL, Weissman JS, Trinh QD.Prev Med. 2016 Apr;85:47-52. doi:
10.1016/j.ypmed.2015.12.019. Epub 2016 Jan 4.PMID:26763164

Relationship between androgen deprivation therapy and community-acquired
respiratory infections in patients with prostate cancer.Schmid M, Hanske J, Ravi P,
Krishna N, Reznor G, Meyer CP, Fisch M, Noldus J, Nguyen PL, Trinh QD.Int J Urol.
2016 Apr;23(4):305-11. doi: 10.1111/iju.13043. Epub 2016 Jan 13.PMID:26763083

Adverse Event Rates, Timing of Complications, and the Impact of Specialty on
Outcomes Following Adrenal Surgery: An Analysis of 30-Day Outcome Data From
the American College of Surgeons National Surgical Quality Improvement Program

(ACS-NSQIP).Sood A, Majumder K, Kachroo N, Sammon JD, Abdollah F, Schmid M,
Hsu L, Jeong W, Meyer CP, Hanske J, Kalu R, Menon M, Trinh QD.Urology. 2016
Apr;90:62-8. doi: 10.1016/j.urology.2015.12.031. Epub 2015 Dec 29.PMID:26743396

Asian Americans and prostate cancer: A nationwide population-based analysis.Chao
GF, Krishna N, Aizer AA, Dalela D, Hanske J, Li H, Meyer CP, Kim SP, Mahal BA,
Reznor G, Schmid M, Choueiri TK, Nguyen PL, O'Leary M, Trinh QD.Urol Oncol.
2016 May;34(5):233.e7-15. doi: 10.1016/j.urolonc.2015.11.013. Epub 2015 Dec
22.PMID:26725248

Complications Following Common Inpatient Urological Procedures: Temporal Trend
Analysis from 2000 to 2010.Meyer CP, Hollis M, Cole AP, Hanske J, O'Leary J, Gupta
S, Löppenberg B, Zavaski ME, Sun M, Sammon JD, Kibel AS, Fisch M, Chun FKH,
Trinh QD.Eur Urol Focus. 2016 Apr;2(1):3-9. doi: 10.1016/j.euf.2015.10.001. Epub
2015 Nov 11.PMID:28723447

Robot-assisted Versus Open Radical Prostatectomy: A Contemporary Analysis of an
All-payer Discharge Database.Leow JJ, Chang SL, Meyer CP, Wang Y, Hanske J,
Sammon JD, Cole AP, Preston MA, Dasgupta P, Menon M, Chung BI, Trinh QD.Eur
Urol. 2016 Nov;70(5):837-845. doi: 10.1016/j.eururo.2016.01.044. Epub 2016 Feb
11.PMID:26874806

The influence of marital status on the use of breast, cervical, and colorectal cancer
screening.Hanske J, Meyer CP, Sammon JD, Choueiri TK, Menon M, Lipsitz SR,
Noldus J, Nguyen PL, Sun M, Trinh QD.Prev Med. 2016 Aug;89:140-5. doi:
10.1016/j.ypmed.2016.05.017. Epub 2016 May 20.PMID:27215758

Relationship between androgen deprivation therapy and community-acquired
respiratory infections in patients with prostate cancer.Schmid M, Hanske J, Ravi P,
Krishna N, Reznor G, Meyer CP, Fisch M, Noldus J, Nguyen PL, Trinh QD.Int J Urol.
2016 Apr;23(4):305-11. doi: 10.1111/iju.13043. Epub 2016 Jan 13.
PMID:26763083

Impact of testosterone replacement therapy on thromboembolism, heart disease, and
obstructive sleep apnea in men.Cole AP, Hanske J, Jiang W, Kwon NK, Lipsitz SR,
Kathrins MN, Learn PA, Sun M, Haider AH, Basaria SS, Trinh QD.BJU Int. 2018 Jan
30. doi: 10.1111/bju.14149. [Epub ahead of print]PMID:29383868

The association of hypoalbuminemia with early perioperative outcomes - A
comprehensive assessment across 16 major procedures.Meyer CP, Rios-Diaz AJ,
Dalela D, Ravi P, Sood A, Hanske J, Chun FKH, Kibel AS, Lipsitz SR, Sun M, Trinh
QD.Am J Surg. 2017 Nov;214(5):871-883. doi: 10.1016/j.amjsurg.2016.11.023. Epub
2016 Dec 3.PMID:29106849

Pneumonia after Major Cancer Surgery: Temporal Trends and Patterns of Care.Trinh
VQ, Ravi P, Abd-El-Barr AE, Jhaveri JK, Gervais MK, Meyer CP, Hanske J, Sammon

JD, Trinh QD.Can Respir J. 2016;2016:6019416. doi: 10.1155/2016/6019416. Epub
2016 May 31.PMID:27445554

Determinants of cancer screening in Asian-Americans.Trinh QD, Li H, Meyer CP,
Hanske J, Choueiri TK, Reznor G, Lipsitz SR, Kibel AS, Han PK, Nguyen PL, Menon
M, Sammon JD.Cancer Causes Control. 2016 Aug;27(8):989-98. doi:
10.1007/s10552-016-0776-8. Epub 2016 Jul 2.PMID:27372292

The influence of marital status on the use of breast, cervical, and colorectal cancer
screening.Hanske J, Meyer CP, Sammon JD, Choueiri TK, Menon M, Lipsitz SR,
Noldus J, Nguyen PL, Sun M, Trinh QD.Prev Med. 2016 Aug;89:140-5. doi:
10.1016/j.ypmed.2016.05.017. Epub 2016 May 20.PMID:27215758

Data on Medicare eligibility and cancer screening utilization.Meyer CP, Allard CB,
Sammon JD, Hanske J, McNabb-Baltar J, Goldberg JE, Reznor G, Lipsitz SR,
Choueiri TK, Nguyen PL, Weissman JS, Trinh QD.Data Brief. 2016 Feb 27;7:679-81.
doi: 10.1016/j.dib.2016.02.049. eCollection 2016 Jun.PMID:27054176

Comparative analysis of the effect of prostatic invasion patterns on cancer-specific
mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder.Vallo S,
Gilfrich C, Burger M, Volkmer B, Boehm K, Rink M, Chun FK, Roghmann F, Novotny
V, Mani J, Brisuda A, Mayr R, Stredele R, Noldus J, Schnabel M, May M, Fritsche HM,
Pycha A, Martini T, Wirth M, Roigas J, Bastian PJ, Nuhn P, Dahlem R, Haferkamp A,
Fisch M, Aziz A.Urol Oncol. 2016 Oct;34(10):432.e1-8. doi:
10.1016/j.urolonc.2016.05.008. Epub 2016 Jun 6.PMID:27283218

Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial
carcinoma of the bladder: development of a tool for clinical decision-making.
BJU Int. 2016;117(2): 272-9 Aziz A, Shariat SF, Roghmann F, Brookman-May S,
Stief CG, Rink M, Chun FK, Fisch M, Novotny V, Froehner M, Wirth MP, Schnabel
MJ, Fritsche HM, Burger M, Pycha A, Brisuda A, Babjuk M, Vallo S, Haferkamp A,
Roigas J, Noldus J, Stredele R, Volkmer B, Bastian PJ, Xylinas E, May M

Wound dehiscence in a sample of 1 776 cystectomies: identification of predictors and
implications for outcomes.BJU Int. 2016;117(6B): E95-E101 Meyer CP, Rios Diaz AJ,
Dalela D, Hanske J, Pucheril D, Schmid M, Trinh VQ, Sammon JD,Menon M, Chun
FK, Noldus J, Fisch M, Trinh QD

Pneumonia after Major Cancer Surgery: Temporal Trends and Patterns of Care.
Can Respir J. 2016;2016: 6019416 Trinh VQ, Ravi P, Abd-El-Barr AE, Jhaveri JK,
Gervais MK, Meyer CP, Hanske J, Sammon JD,Trinh QD

In Reply.Dtsch Arztebl Int. 2016;113(9): 149 Brock M

Relationship between androgen deprivation therapy and community-acquired
respiratory infections in patients with prostate cancer.
Int J Urol. 2016;23(4): 305-11 Schmid M, Hanske J, Ravi P, Krishna N, Reznor G,
Meyer CP, Fisch M, Noldus J, Nguyen PL, Trinh QD

The influence of marital status on the use of breast, cervical, and colorectal cancer
screening.Prev Med. 2016;89: 140-5 Hanske J, Meyer CP, Sammon JD, Choueiri TK,
Menon M, Lipsitz SR, Noldus J, Nguyen PL, Sun
M, Trinh QD

Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for
precision imaging of the androgen receptor axis.Sci Transl Med.
2016;8(367):367ra167 Thorek DL, Watson PA, Lee SG, Ku AT, Bournazos S, Braun
K, Kim K, Sjöström K, Doran MG, Lamminmäki U, Santos E, Veach D, Turkekul M,
Casey E, Lewis JS, Abou DS, van Voss MR, Scardino PT, Strand SE, Alpaugh ML,
Scher HI, Lilja H, Larson SM, Ulmert D

Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical
Parameters before Radical Cystectomy--A Prospective Multicenter Study.
Urol Int. 2016;96(1): 57-64 Martini T, Aziz A, Roghmann F, Rink M, Chun FK, Fisch
M, Trojan L, Hakenberg OW, Zastrow S, Wirth MP, Moersdorf J, Brookman-May S,
Stief CG, Haferkamp A, Wagenlehner F, Hohenfellner M, Herrmann E, Lusuardi L,
Grimm MO, Müller SC, Roigas J, Bastian PJ, Gierth M, Burger M, Pycha A, Seitz C,
May M, Bolenz C

The Effect of Resident Involvement on Surgical Outcomes for Common Urologic
Procedures: A Case Study of Uni- and Bilateral Hydrocele Repair.
Urology. 2016;94: 70-6 Löppenberg B, Cheng PJ, Speed JM, Cole AP, Vetterlein
MW, Kibel AS, Noldus J, Trinh QD, Meyer CP

Editorial Comment. Urology. 2016;97: 116-117 Noldus J

Treatment patterns, testicular loss and disparities in inpatient surgical management
of testicular torsion in boys: a population-based study 1998-2010.Sood A, Li H,
Suson KD, Majumder K, Sedki M, Abdollah F, Sammon JD, Friedman A, Löppenberg
B, Lakshmanan Y, Trinh QD, Elder JS.BJU Int. 2016 Dec;118(6):969-979. doi:
10.1111/bju.13557. Epub 2016 Jul 19.PMID:27322784

The Impact of Local Treatment on Overall Survival in Patients with Metastatic
Prostate Cancer on Diagnosis: A National Cancer Data Base Analysis.Löppenberg B,
Dalela D, Karabon P, Sood A, Sammon JD, Meyer CP, Sun M, Noldus J, Peabody
JO, Trinh QD, Menon M, Abdollah F.Eur Urol. 2017 Jul;72(1):14-19. doi:
10.1016/j.eururo.2016.04.031. Epub 2016 May 9.PMID:27174537

Contemporary Role of the Decipher® Test in Prostate Cancer Management: Current

Practice and Future Perspectives.Dalela D, Löppenberg B, Sood A, Sammon J,
Abdollah F.Rev Urol. 2016;18(1):1-9.PMID:27162506

The Effect of Resident Involvement on Surgical Outcomes for Common Urologic
Procedures: A Case Study of Uni- and Bilateral Hydrocele Repair.Löppenberg B,
Cheng PJ, Speed JM, Cole AP, Vetterlein MW, Kibel AS, Noldus J, Trinh QD, Meyer
CP.Urology. 2016 Aug;94:70-6. doi: 10.1016/j.urology.2016.03.045. Epub 2016 Apr
20.PMID:27107625

2015

The Effect of Resident Involvement on Perioperative Outcomes in Transurethral
Urologic Surgeries.Allard CB, Meyer CP, Gandaglia G, Chang SL, Chun FK, Gelpi-
Hammerschmidt F, Hanske J, Kibel AS, Preston MA, Trinh QD.J Surg Educ. 2015
Sep-Oct;72(5):1018-25. doi: 10.1016/j.jsurg.2015.04.012. Epub 2015 May
21.PMID:26003818

An evaluation of the timing of surgical complications following nephrectomy: data
from the American College of Surgeons National Surgical Quality Improvement
Program (ACS-NSQIP).Sood A, Abdollah F, Sammon JD, Kapoor V, Rogers CG,
Jeong W, Klett DE, Hanske J, Meyer CP, Peabody JO, Menon M, Trinh QD.World J
Urol. 2015 Dec;33(12):2031-8. doi: 10.1007/s00345-015-1564-x. Epub 2015 Apr
25.PMID:25910477

A Comparison of 30-Day Perioperative Outcomes in Open Versus Minimally Invasive
Nephroureterectomy for Upper Tract Urothelial Carcinoma: Analysis of 896 Patients
from the American College of Surgeons-National Surgical Quality Improvement
Program Database.
Hanske J, Sanchez A, Schmid M, Meyer CP, Abdollah F, Feldman AS, Kibel AS,
Sammon JD, Menon M, Eswara JR, Noldus J, Trinh QD.J Endourol. 2015
Sep;29(9):1052-8. doi: 10.1089/end.2015.0137. Epub 2015 Jun 11.PMID:25891843

The impact of resident involvement in male one-stage anterior urethroplasties.
Meyer CP, Hanske J, Friedlander DF, Schmid M, Dahlem R, Trinh VQ, Chang SL,
Kibel AS, Chun FK, Fisch M, Trinh QD, Eswara JR.Urology. 2015 Apr;85(4):937-41.
doi: 10.1016/j.urology.2015.01.010.PMID:25817121

Contemporary nationwide patterns of self-reported prostate-specific antigen
screening in US veterans.Pucheril D, Sammon JD, Sood A, Abdollah F, Choueiri TK,
Meyer C, Hanske J, Kim SP, Nguyen PL, Kibel AS, Weissman JS, Menon M, Trinh
QD.Urol Oncol. 2015 Dec;33(12):503.e7-15. doi: 10.1016/j.urolonc.2015.07.019.
Epub 2015 Aug 28.PMID:26319352

Inpatients hypospadias care: trends and outcomes from the American nationwide
inpatient sample.Meyer C, Sukumar S, Sood A, Hanske J, Vetterlein M, Elder JS,
Fisch M, Trinh QD, Friedman AA.Korean J Urol. 2015 Aug;56(8):594-600. doi:

10.4111/kju.2015.56.8.594. Epub 2015 Jul 24. Erratum in: Korean J Urol. 2015
Sep;56(9):670. PMID:26279829

Patient Characteristics and Perioperative Outcomes of Female Urethral
Diverticulectomy: Analysis of a Multi-Institutional Prospective Database.Raup VT,
Hess DS, Hanske J, Schmid M, Varda B, Das A, Trinh QD, Eswara JR.Urology. 2015
Oct;86(4):712-5. doi: 10.1016/j.urology.2015.07.007. Epub 2015 Jul
17.PMID:26190087

How can we improve surgical outcomes?Hanske J, Meyer CP, Trinh QD.BJU Int.
2015 Dec;116(6):835-6. doi: 10.1111/bju.13056. No abstract available.
PMID:26542324

Open Versus Robotic Radical Prostatectomy in Obese Men.Ellimoottil C, Roghmann
F, Blackwell R, Kadlec A, Greco K, Quek ML, Sun M, Trinh QD, Gupta G.Curr Urol.
2015 Sep;8(3):156-61. doi: 10.1159/000365708. Epub 2015 Sep 4.PMID:26889136

[Segmental testicular infarction. Unusual complication of intravenous immunoglobulin
therapy for multifocal motor neuropathy].
Rüb J, Rehmann R, von Landenberg N, Roghmann F, Stude P, Tegenthoff M,
Noldus J, Pastor J.Urologe A. 2015 Oct;54(10):1421-4. doi: 10.1007/s00120-015-
3941-x. German. PMID:26303740

Perioperative outcomes after radical cystectomy at NCI-designated centres: Are they
any better?Roghmann F, Ravi P, Hanske J, Meyer CP, Preston MA, Noldus J, Trinh
QD.Can Urol Assoc J. 2015 May-Jun;9(5-6):207-12. doi:
10.5489/cuaj.2621.PMID:26225174

Prognostic Model for Predicting Survival in Patients with Disease Recurrence
Following Radical Cystectomy.Kluth LA, Xylinas E, Rieken M, Kent M, Ikeda M,
Matsumoto K, Hagiwara M, Kikuchi E, Bing MT, Gupta A, Sewell JM, Konety BR,
Todenhöfer T, Schwentner C, Masson-Lecomte A, Vordos D, Roghmann F, Noldus J,
Razmaria AA, Smith ND, Comploj E, Pycha A, Rink M, Baniel J, Mano R, Novara G,
Aziz A, Fritsche HM, Brisuda A, Bivalacqua T, Gontero P, Boorjian SA, Vickers AJ,
Shariat SF.Eur Urol Focus. 2015 Aug;1(1):75-81. doi: 10.1016/j.euf.2014.10.003.
Epub 2015 May 28.PMID:28723361

Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical
Parameters before Radical Cystectomy--A Prospective Multicenter Study.
Martini T, Aziz A, Roghmann F, Rink M, Chun FK, Fisch M, Trojan L, Hakenberg OW,
Zastrow S, Wirth MP, Moersdorf J, Brookman-May S, Stief CG, Haferkamp A,
Wagenlehner F, Hohenfellner M, Herrmann E, Lusuardi L, Grimm MO, Müller SC,
Roigas J, Bastian PJ, Gierth M, Burger M, Pycha A, Seitz C, May M, Bolenz C.
Urol Int. 2016;96(1):57-64. doi: 10.1159/000433606. Epub 2015 Jul
1.PMID:26139354